2025 HCPCS Code Q5112
Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
| Short Description | Inj ontruzant 10 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | July 01, 2019 |
| HCPCS Action Effective Date | October 01, 2023 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q5129 - Inj, vegzelma, 10 mg
- Q5130 - Inj, fylnetra, 0.5 mg
- Q5131 - Inj, idacio, 20 mg
- Q5132 - Inj, abrilada, 10 mg
- Q5133 - Inj, tofidence, 1 mg
- Q5134 - Inj, tyruko, 1 mg
- Q5137 - Inj, wezlana, sub cu, 1 mg
- Q5138 - Inj, wezlana, iv, 1 mg
- Q9001 - Chaplain assessment
- Q9002 - Chaplain counsel individu
- Q9003 - Chaplain counsel group
- Q9004 - Va whole health partner serv
- Q9950 - Inj sulf hexa lipid microsph
- Q9951 - Locm >= 400 mg/ml iodine,1ml
- Q9953 - Inj fe-based mr contrast,1ml
- Q9954 - Oral mr contrast, 100 ml
- Q9955 - Inj perflexane lip micros,ml
- Q9956 - Inj octafluoropropane mic,ml
- Q9957 - Inj perflutren lip micros,ml
- Q9958 - Hocm <=149 mg/ml iodine, 1ml